Durable cell and gene therapy potential patient and financial impact: US projections of product approvals, patients treated, and product revenues

Forecasting drug utilization and expenditure: ten years of experience in Stockholm

(2020) Love Linnér et al.   BMC HEALTH SERVICES RESEARCH

Clinical Development of Gene Therapies: The First Three Decades and Counting.

(2020) Larissa Lapteva et al.   Molecular Therapy-Methods & Clinical Development

Financial Toxicity From Generic Specialty Drug Use

(2020) Katrina A. Fischer et al.   JAMA Oncology

The Horizon Scanning System at The Italian Medicines Agency

(2019) Michele Marangi et al.   DRUG DISCOVERY TODAY

Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System

(2019) Casey Quinn et al.   VALUE IN HEALTH

Estimation of clinical trial success rates and related parameters

(2018) Chi Heem Wong et al.   BIOSTATISTICS

Innovation in the pharmaceutical industry: New estimates of R&D costs

(2016) Joseph A. DiMasi et al.   JOURNAL OF HEALTH ECONOMICS

Drug launch curves in the modern era

(2016) Seth Robey et al.   NATURE REVIEWS DRUG DISCOVERY

Nation-scale adoption of new medicines by doctors: an application of the Bass diffusion model

(2012) Adam G Dunn et al.   BMC HEALTH SERVICES RESEARCH